a near-significant trendp = 0.0541
Among early-onset cases, the median age at diagnosis was slightly higher in FOLFOX-treated patients (42 years; IQR 36–47) compared with those who did not receive FOLFOX (40 years; IQR 34–43), with a near-significant trend ( p = 0.0541).